SRSF1 regulates the alternative splicing of MYO1B gene and inhibits its protein level, thereby inhibiting the proliferation, metastasis and stem cell properties of breast cancer cells, and promoting the chemosensitivity of drug-resistant breast cancer cells. Here, MYO1B is linked to breast carcinoma.